Italy Pediatric Medical Devices Market Overview, 2031

Key Insights

• According to the research report, "Italy Pediatric Medical Devices Market Outlook, 2031," published by Bonafide Research, the Italy Pediatric Medical Devices Market is anticipated to add to more than 298.12 Million by 2026-31.
• Italy houses Europe's largest pediatric research hospital, Ospedale Pediatrico Bambino Gesù in Rome, which operates over 600 beds (including 62 intensive and neonatal ICU beds) and handles over 33,000 surgical/interventional procedures and 430 ongoing clinical studies annually. The hospital serves as a global benchmark for pediatric cardiac assist devices, artificial heart implantations, and rare disease tracking via Orphanet Italy.
• Pediatric medtech development in Italy is backed by INCiPiT (Italian Network for Paediatric Clinical Trials), a national research consortium connecting leading Scientific Institutes for Research, Hospitalization and Healthcare (IRCCS). INCiPiT streamlines clinical validation and ethical reviews for pediatric medical devices across more than 20 national clinical research centers, reducing trial setup delays for complex, small-batch pediatric hardware.
• Public sector facilities account for over 75% of total medical device procurement in Italy. However, pediatric medtech adoption faces regulatory and budgetary pressures due to the strict enforcement of the EU Medical Device Regulation (EU MDR 2017/745) and Italy's national Payback financial mechanism (payback dispositivi medici), which requires medtech companies to retroactively cover public regional health expenditure overruns.

Market Outlook

• Driven by Italy's National Recovery and Resilience Plan (PNRR) investments in digital health, the market is rapidly pivoting toward child-friendly wearable sensors, remote continuous glucose monitoring (CGM), and AI-enabled home telemetry. This shift aims to transition pediatric chronic care (such as epilepsy, juvenile diabetes, and severe asthma) out of acute hospital wards into home-based remote management.
• Regional public purchasing platforms such as CONSIP at the national level and regional entities like ARIA (Lombardy) are increasingly adopting Value-Based Procurement (VBP) criteria. Tenders are shifting away from lowest-unit-price models toward evaluating long-term clinical efficiency, reductions in pediatric bed-days, and minimized surgical revision rates for specialized pediatric hardware.
• The market ecosystem is anchored by key industry associations like Confindustria Dispositivi Medici and research networks like INCiPiT, alongside leading domestic medtech producers and global leaders operating in Italy, including Bellco (Medtronic), Burke & Burke, Chiesi Farmaceutici, GE HealthCare, Siemens Healthineers, and Philips Healthcare.

Market Dynamics

Driver: NICU expansion
The demand for pediatric medical devices in Italy is driven by high specialized care needs in tertiary referral centers, particularly for congenital heart diseases, neonatal respiratory distress, and rare childhood disorders. Italy maintains advanced neonatal care networks, where high survival rates of extremely premature infants drive steady demand for non-invasive respiratory devices, micro-bore catheters, and specialized neonatal incubators.
Challenge: Stricter regulatory hurdles under EU MDR
The stringent evidentiary demands of the EU Medical Device Regulation (EU MDR 2017/745) make clinical trials and recertifications for low-volume, niche pediatric hardware complex and costly. This issue is compounded by Italy’s controversial payback mechanism (payback dispositivi medici), under which medtech suppliers are required to contribute to regional healthcare procurement budget overruns. The legal and financial uncertainties associated with payback levies create financial strain, discouraging some foreign and domestic medtech developers from bidding on low-margin pediatric tenders.
Trend: Telemedicine, wearables & decentralized care via PNRR funding
Italy’s healthcare system is modernizing through the National Recovery and Resilience Plan (PNRR), which allocates substantial capital to digital health, community health centers (Case della Comunità), and remote patient monitoring infrastructure. This digital transformation is accelerating the uptake of child-friendly wearable sensors, smart inhalers, and AI-enabled continuous glucose monitoring (CGM) systems that migrate long-term pediatric management out of acute hospital wards into home settings.

Procurement and Industry Impact

• Public healthcare accounts for over 75% of total medical device procurement in Italy. Purchasing is heavily centralized through national purchasing bodies such as CONSIP and key regional procurement agencies (e.g., ARIA in Lombardy, So.Re.Sa. in Campania). These entities issue aggregated tenders for high-demand pediatric and neonatal consumables, using centralized buying power to secure competitive unit pricing across regional hospital networks.
• Italian regional procurement boards are moving away from awarding contracts solely based on the lowest initial price (prezzo più basso). Under modern public procurement guidelines, tenders for complex pediatric devices evaluate the Most Economically Advantageous Tender (MEAT) criteria. Tenders weigh long-term clinical efficiency, reductions in pediatric bed-days, minimized surgical complication rates, and total cost of care.
• o stabilize the medical device supply chain following lengthy litigation before the Italian Constitutional Court and Regional Administrative Courts (TAR), Italian tax authorities and health ministries introduced structured settlement measures including granting 52% to 75% reductions on retroactively calculated regional payback obligations and establishing clear VAT deduction procedures. These regulatory clarifications help reduce financial risk for suppliers, protecting the steady delivery of critical medtech imports to Italian pediatric units.

Segment Analysis

Italy Pediatric Medical Devices Market By Product
• In vitro diagnostic (IVD) devices are fundamental to Italy's pediatric healthcare system, supporting newborn screening, infectious disease diagnosis, metabolic disorder detection, and genetic testing. Italian clinical laboratories are increasingly incorporating molecular diagnostics, multiplex PCR, and automated laboratory platforms to improve diagnostic speed and accuracy for pediatric patients. Italy has operated a nationwide expanded newborn screening program since 2016, and today over 400,000 newborns are screened annually for more than 40 inherited metabolic disorders, making pediatric IVDs an essential component of neonatal healthcare.
• Pediatric cardiology devices are widely used in Italy's tertiary children's hospitals and specialized cardiac centers to manage congenital heart defects and rhythm disorders. Italian clinicians increasingly utilize miniaturized catheter-based devices, pediatric electrophysiology systems, and high-resolution cardiac imaging technologies that reduce procedural invasiveness while improving recovery times. Research collaborations between pediatric cardiology centers and medical device manufacturers continue to drive innovation in child-specific cardiovascular care.
• Anesthesia and respiratory care devices are extensively deployed in neonatal intensive care units (NICUs), pediatric operating rooms, and pediatric emergency departments. Hospitals are adopting advanced neonatal ventilators, non-invasive respiratory support technologies, and pediatric anesthesia systems capable of delivering highly precise ventilation volumes for infants. Clinical practice increasingly focuses on reducing ventilation-related complications through smart respiratory monitoring and individualized ventilation strategies.
• NICU devices remain an important product category due to Italy's well-developed neonatal care network. Hospitals rely on neonatal incubators, radiant warmers, phototherapy units, infusion pumps, and integrated monitoring systems to support premature and critically ill infants. Italy recorded approximately 370,000 live births in 2024, sustaining demand for neonatal intensive care technologies despite declining birth rates.
• Diagnostic imaging devices are increasingly optimized for pediatric applications through low-dose CT protocols, rapid MRI acquisition, and advanced ultrasound systems that reduce radiation exposure and minimize the need for sedation. Italian hospitals are also implementing AI-assisted imaging software to improve diagnostic precision in pediatric neurology, orthopedics, and congenital disease assessment while enhancing workflow efficiency.
• Monitoring devices are evolving toward continuous and wireless patient monitoring across pediatric intensive care units and neonatal wards. Italian healthcare providers are increasingly integrating centralized monitoring platforms capable of combining ECG, pulse oximetry, respiratory monitoring, and blood pressure measurements into unified digital systems. These technologies facilitate early clinical intervention and improve patient safety in critically ill children.
• Other products category includes pediatric infusion pumps, orthopedic implants, ophthalmic devices, enteral feeding systems, rehabilitation equipment, and pediatric surgical instruments. Italy's strong manufacturing expertise in biomedical engineering and precision medical technologies supports the development of child-specific devices tailored to pediatric anatomical and physiological requirements. According to Confindustria Dispositivi Medici, Italy has more than 4,500 companies operating across the medical device sector, supporting innovation and domestic supply.

Italy Pediatric Medical Devices Market By End-User
• Hospitals remain the primary end users of pediatric medical devices because they provide neonatal intensive care, pediatric surgery, cardiology, oncology, emergency medicine, and advanced diagnostics. Italy's university hospitals and specialized children's hospitals are early adopters of advanced pediatric technologies, including minimally invasive surgical equipment, neonatal monitoring platforms, and digital imaging systems. The country has more than 1,000 public and accredited private hospitals, providing an extensive network for pediatric healthcare delivery.
• Pediatric clinics primarily utilize diagnostic equipment, vaccination-related devices, patient monitoring systems, and point-of-care diagnostic technologies for preventive and routine child healthcare. Italian clinics are increasingly incorporating digital health tools that facilitate developmental assessments, chronic disease monitoring, and electronic communication with hospital specialists, improving continuity of pediatric care.
• Ambulatory Surgical Centers are expanding their role in performing low-risk pediatric procedures such as ENT surgery, ophthalmology, minor orthopedic interventions, and gastrointestinal endoscopy. Compact anesthesia machines, portable imaging systems, and advanced patient monitoring technologies enable efficient same-day procedures while reducing hospital occupancy and improving patient convenience.
• Home healthcare continues to gain importance for children requiring long-term respiratory support, enteral nutrition, infusion therapy, diabetes management, and neurological care. Portable ventilators, wearable monitoring devices, connected infusion pumps, and telemedicine-enabled equipment are increasingly supporting family-centered care while reducing repeated hospital admissions for chronically ill pediatric patients.
• Diagnostic laboratories and research institutes play a vital role in newborn screening, pediatric genomics, molecular diagnostics, and rare disease research. Italy has strengthened collaborations between research institutes, university hospitals, and biotechnology companies to advance precision medicine for children. Increasing adoption of automated laboratory technologies and next-generation sequencing continues to enhance early diagnosis and personalized treatment strategies for pediatric patients.


Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Pediatric Medical Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• In Vitro Diagnostic (IVD) Devices
• Cardiology Devices
• Anesthesia & Respiratory Care Devices
• Neonatal ICU (NICU) Devices
• Diagnostic Imaging Devices
• Monitoring Devices
• Other Products

By End-User
• Hospitals
• Pediatric Clinics
• Ambulatory Surgical Centers (ASCs)
• Home Healthcare / Homecare Settings
• Diagnostic Laboratories & Research Institutes